Skip to main content

TOBAM

Position in NBIX — Neurocrine Biosciences Inc

CIK 1527488 PARIS, I0

Position in NBIX

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$706,182
+$697,956 QoQ
Shares Held
4,190
+7124.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#436
of 768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TOBAM holds $6,598,583 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (10.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
4,190 $706,182

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $706,182 4,190
2025-12-31 $8,226 58
2025-09-30 $707,655 5,041
2025-06-30 $1,204,612 9,584
2025-03-31 $2,434,527 22,012
2024-12-31 $4,268,082 31,268
2024-09-30 $8,439,404 73,246
2024-06-30 $12,454,316 90,465
2024-03-31 $24,584,653 178,253
2023-12-31 $29,888,570 226,841
2023-09-30 $33,433,200 297,184
2023-06-30 $29,394,724 311,715
2023-03-31 $36,682,532 362,404
2022-12-31 $34,379,609 287,840
2022-09-30 $30,468,568 286,871
2022-06-30 $29,877,035 306,494
2022-03-31 $20,292,843 216,457
2021-12-31 $16,331,603 191,753
2021-09-30 $12,004,575 125,165
2021-06-30 $12,185,826 125,214
2021-03-31 $9,278,039 95,404
2020-12-31 $5,765,856 60,155
2020-09-30 $3,010,384 31,306
2020-06-30 $6,668,032 54,656
2020-03-31 $5,029,247 58,108